OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
41
Results
Show all
Save search
Copy query
Show results for
Unknown
(41)
Publication Date
Release Date
2021
(11)
2023
(6)
2022
(6)
2020
(3)
2025
(2)
2018
(2)
2013
(2)
2011
(2)
2026
(1)
2024
(1)
2019
(1)
2014
(1)
2012
(1)
2009
(1)
2002
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
DNA sequence and mutational analyses of the pVir plasmid of Campylobacter jejuni 81-176.
Not available
S-EPMC130303
|
biostudies-literature
Cite
Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling.
Not available
S-EPMC9849236
|
biostudies-literature
Cite
Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics.
Not available
S-EPMC6981144
|
biostudies-literature
Cite
An aminosterol breaks the autocatalytic cycle of Aβ<sub>42</sub> aggregation and protects cell membranes from its soluble aggregates.
Not available
S-EPMC12280974
|
biostudies-literature
Cite
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England.
Not available
S-EPMC8522415
|
biostudies-literature
Cite
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
Not available
S-EPMC7976383
|
biostudies-literature
Cite
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
Not available
S-EPMC9295078
|
biostudies-literature
Cite
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Not available
S-EPMC3829604
|
biostudies-literature
Cite
Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.
Not available
S-EPMC9240035
|
biostudies-literature
Cite
Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform.
Not available
S-EPMC10694966
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets